Kingdon Capital Management’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Kingdon Capital Management’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-401,200	Closed	-$21.1M	–	195
2014 Q4	$21.1M	Sell	401,200 -22,679	-5%	-$666K	0.92%	33
2014 Q3	$10.9M	Buy	423,879 +119,803	+39%	+$2.55M	0.49%	56
2014 Q2	$6.77M	Sell	304,076 -97,657	-24%	-$2.14M	0.26%	108
2014 Q1	$12.4M	Buy	+401,733	New	+$10.8M	0.63%	50

Other funds holding ASPX

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kingdon Capital Management's ASPX Position: Q1 2015 in Review

Kingdon Capital Management sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q1 2015, closing a stake of 401,200 shares — an estimated $21.1M sold.

Kingdon Capital Management first reported a position in ASPX in Q1 2014 and held it in 4 quarters. The position peaked at $21.1M in Q4 2014. 138 funds tracked by Wall St. Rank hold ASPX as of Q1 2015.

Kingdon Capital Management reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
Kingdon Capital Management sold 401,200 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q1 2015, an estimated $21.1M.
Kingdon Capital Management first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 4 quarters.
Kingdon Capital Management's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $21.1M in Q4 2014.
138 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q1 2015.

Based on Kingdon Capital Management's 13F filing for Q1 2015, filed 15 May 2015.